首页> 外国专利> FORMULATIONS FOR DENTAL APPLICATION WITH A LOW LEVEL OF SHRINKAGE, MICROFILTRATION, AND TOXICITY BY THE USE OF AN ACRYLIC MONOMER ORTHOS-PYROCARBONATE AND BIS-GMA.

FORMULATIONS FOR DENTAL APPLICATION WITH A LOW LEVEL OF SHRINKAGE, MICROFILTRATION, AND TOXICITY BY THE USE OF AN ACRYLIC MONOMER ORTHOS-PYROCARBONATE AND BIS-GMA.

机译:通过使用丙烯酸单体邻位焦碳酸酯和BIS-GMA进行低收缩,微滤和低毒性牙科应用的配方。

摘要

The present invention relates to the process of preparation and use of ortho-pyrocarbonate urethane dimethyl acrylate monomer (SOF-IF-DMA) as a dental restorative material, which possesses mainly anti-shrinkage, microfiltration, toxicity, high conversion, and good mechanical properties. It aims to provide dental formulations from SOC-IF-DMA and Bis-GMA at different percentages by weight, (0/100) (25/75) (50/50) (75/25) and (100/0) respectively. The efficiency of the novel formulations based on SOC-IF-DMA/Bis-GMA is evaluated by conversion of double bonds (CDE) by the kinetics of photo polymerization in real time (RT-FTIR) where conversion values ??of up to 71%. The viscoelastic properties values ??of up to 10189MPa and for the flexural strength modules of up to 7161MPa. Said formulations in contraction tests and in vitro microfiltration using premolar teeth can reduce shrinkage and microfiltration of up to 51%. Further, combinations between SOC-IF-DMA/Bis-GMA manage to make the use of the two acrylic monomers more efficient since they proved to increase the final properties in the evaluated dental resins. Likewise, the cytotoxicity tests of the novel formulations showed that those based on SOC-IF-DMA turn out to be non-toxic when they contain more than 50% by weight of Bis-GMA.
机译:本发明涉及原焦碳酸盐氨基甲酸酯丙烯酸二甲酯单体(SOF-IF-DMA)的制备和使用方法,该材料主要具有抗收缩,微滤,毒性,高转化率和良好的机械性能。 。它旨在提供不同重量百分比分别为(0/100)(25/75)(50/50)(75/25)和(100/0)的SOC-IF-DMA和Bis-GMA制成的牙科配方。基于SOC-IF-DMA / Bis-GMA的新型制剂的效率通过实时的光聚合动力学(RT-FTIR)通过双键转换(CDE)进行评估,其中转换值高达71 %。粘弹性性能值最高为10189MPa,而抗弯强度模量最高为7161MPa。所述制剂在收缩试验和使用前磨牙的体外微滤中可减少收缩和微滤达51%。此外,SOC-IF-DMA / Bis-GMA之间的组合设法使两种丙烯酸单体的使用更加有效,因为它们被证明可以增加所评估的牙科树脂的最终性能。同样,新制剂的细胞毒性试验表明,当基于SOC-IF-DMA的制剂中Bis-GMA的含量超过50%时,它们是无毒的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号